Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01682-4/fulltext?dgcid=hubspot_email_conferencealerts_esc25&utm_campaign=conferencealerts&utm_medium=email&_hsenc=p2ANqtz--hNWBQa8sNfKJ3NeTL8-vvyYFxyS29BnH7nm0Eprkpu0V0XkDkOBjQZOUYo5jtpn06418xQ2sdnUXr4lfPhISILUXwFQ&_hsmi=378460064&utm_content=378460064&utm_source=hs_email